全文获取类型
收费全文 | 5324篇 |
免费 | 185篇 |
国内免费 | 63篇 |
出版年
2023年 | 12篇 |
2022年 | 47篇 |
2021年 | 82篇 |
2020年 | 22篇 |
2019年 | 9篇 |
2018年 | 35篇 |
2017年 | 31篇 |
2016年 | 327篇 |
2015年 | 1143篇 |
2014年 | 1449篇 |
2013年 | 238篇 |
2012年 | 315篇 |
2011年 | 280篇 |
2010年 | 183篇 |
2009年 | 113篇 |
2008年 | 125篇 |
2007年 | 100篇 |
2006年 | 72篇 |
2005年 | 131篇 |
2004年 | 154篇 |
2003年 | 115篇 |
2002年 | 85篇 |
2001年 | 81篇 |
2000年 | 42篇 |
1999年 | 28篇 |
1998年 | 19篇 |
1997年 | 21篇 |
1996年 | 13篇 |
1995年 | 8篇 |
1994年 | 9篇 |
1993年 | 36篇 |
1992年 | 29篇 |
1991年 | 14篇 |
1990年 | 19篇 |
1989年 | 25篇 |
1988年 | 11篇 |
1987年 | 8篇 |
1986年 | 14篇 |
1985年 | 27篇 |
1984年 | 4篇 |
1983年 | 4篇 |
1982年 | 4篇 |
1980年 | 4篇 |
1979年 | 4篇 |
1978年 | 4篇 |
1973年 | 5篇 |
1966年 | 3篇 |
1957年 | 6篇 |
1955年 | 4篇 |
1943年 | 3篇 |
排序方式: 共有5572条查询结果,搜索用时 15 毫秒
951.
952.
Carina Cesar Bryan E. Shepherd Cathy A. Jenkins Massimo Ghidinelli Jose Luis Castro Valdiléa Gon?alves Veloso Claudia P. Cortes Denis Padgett Brenda Crabtree-Ramirez Eduardo Gotuzzo Valeria Fink Adriana Duran Omar Sued Catherine C. McGowan Pedro Cahn for The Caribbean Central South America Network for HIV Epidemiology 《PloS one》2014,9(9)
Background
Access to highly active antiretroviral therapy (HAART) is expanding in Latin America. Many patients require second and third line therapy due to toxicity, tolerability, failure, or a combination of factors. The need for third line HAART, essential for program planning, is not known.Methods
Antiretroviral-naïve patients ≥18 years who started first HAART after January 1, 2000 in Caribbean, Central and South America Network (CCASAnet) sites in Argentina, Brazil, Honduras, Mexico, and Peru were included. Clinical trials participants were excluded. Third line HAART was defined as use of darunavir, tipranavir, etravirine, enfuvirtide, maraviroc or raltegravir. Need for third line HAART was defined as virologic failure while on second line HAART.Results
Of 5853 HAART initiators followed for a median of 3.5 years, 310 (5.3%) failed a second line regimen and 44 (0.8%) received a third line regimen. Cumulative incidence of failing a 2nd or starting a 3rd line regimen was 2.7% and 6.0% three and five years after HAART initiation, respectively. Predictors at HAART initiation for failing a second or starting a third line included female sex (hazard ratio [HR] = 1.54, 95% confidence interval [CI] 1.18–2.00, p = 0.001), younger age (HR = 2.76 for 20 vs. 40 years, 95% CI 1.86–4.10, p<0.001), and prior AIDS (HR = 2.17, 95% CI 1.62–2.90, p<0.001).Conclusions
Third line regimens may be needed for at least 6% of patients in Latin America within 5 years of starting HAART, a substantial proportion given the large numbers of patients on HAART in the region. Improved accessibility to third line regimens is warranted. 相似文献953.
Colm G. Connolly Amanda Bischoff-Grethe Stephan J. Jordan Steven Paul Woods Ronald J. Ellis Martin P. Paulus Igor Grant for The Translational Methamphetamine AIDS Research Center Group 《PloS one》2014,9(10)
Background
Risky decision-making is commonly observed in persons at risk for and infected with HIV and is associated with executive dysfunction. Yet it is currently unknown whether HIV alters brain processing of risk-taking decision-making.Methods
This study examined the neural substrate of a risky decision-making task in 21 HIV seropositive (HIV+) and 19 seronegative (HIV-) comparison participants. Functional magnetic resonance imaging was conducted while participants performed the risky-gains task, which involves choosing among safe (20 cents) and risky (40/80 cent win or loss) choices. Linear mixed effects analyses examining group and decision type were conducted. Robust regressions were performed to examine the relationship between nadir CD4 count and Kalichman sexual compulsivity and brain activation in the HIV+ group. The overlap between the task effects and robust regressions was explored.Results
Although there were no serostatus effects in behavioral performance on the risky-gains task, HIV+ individuals exhibited greater activation for risky choices in the basal ganglia, i.e. the caudate nucleus, but also in the anterior cingulate, dorsolateral prefrontal cortex, and insula relative to the HIV- group. The HIV+ group also demonstrated reduced functional responses to safe choices in the anterior cingulate and dorsolateral prefrontal cortex relative to the HIV- group. HIV+ individuals with higher nadir CD4 count and greater sexual compulsivity displayed lower differential responses to safe versus risky choices in many of these regions.Conclusions
This study demonstrated fronto-striatal loop dysfunction associated with HIV infection during risky decision-making. Combined with similar between-group task behavior, this suggests an adaptive functional response in regions critical to reward and behavioral control in the HIV+ group. HIV-infected individuals with higher CD4 nadirs demonstrated activation patterns more similar to seronegative individuals. This suggests that the severity of past immunosuppression (CD4 nadir) may exert a legacy effect on processing of risky choices in the HIV-infected brain. 相似文献954.
Alexander A. Martínez Yamitzel Y. Zaldivar CSS-NAT Group Zoila De Castillo Alma Y. Ortiz Yaxelis Mendoza Juan Cristina Juan M. Pascale 《PloS one》2014,9(8)
Hepatitis B Virus (HBV) is an infectious agent that causes more than half of the cases of liver disease and cancer in the world. Globally there are around 250 million people chronically infected with this virus. Despite 16% of the cases of liver disease in Central America are caused by HBV, the information regarding its genetic diversity, genotypes and circulation is scarce. The purpose of this study was to evaluate the genetic variability of the HBV genotypes from HBV-DNA positive samples obtained from screening blood donors at the Social Security System of Panama and to estimate its possible origin. From 59,696 blood donors tested for HBV infection during 2010–2012, there were 74 HBV-DNA positive subjects. Analysis of the partial PreS2-S region of 27 sequences shows that 21% of the infections were caused by genotype A, 3% by genotype D and 76% by genotype F. In addition, we were able to confirm circulation of six sub-genotypes A1, A2, A3, D4, F3, F1 and a proposed new sub-genotype denominated F5pan. We found a confinement of sub-genotypes F1 and F5pan to the western area of Panama. The tMRCA analysis suggests a simultaneous circulation of previously described sub-genotypes rather than recent introductions of the Panamanian sub-genotypes in the country. Moreover, these results highlight the need of more intensive research of the HBV strains circulating in the region at the molecular level. In conclusion, Panama has a high HBV genotype diversity that includes a new proposed sub-genotype, an elevated number of PreCore-Core mutations, and confinement of these variants in a specific geographical location. 相似文献
955.
956.
957.
958.
Ana Maria B. Menezes Rogelio Pérez-Padilla Fernando César Wehrmeister Maria Victorina Lopez-Varela Adriana Mui?o Gonzalo Valdivia Carmen Lisboa José Roberto B. Jardim Maria Montes de Oca Carlos Talamo Renata Bielemann Mariana Gazzotti Ruy Laurenti Bartolomé Celli Cesar G. Victora for the PLATINO team 《PloS one》2014,9(10)
Objective
To determine whether the presence of chronic obstructive lung disease (COPD) and reduction of lung function parameters were predictors of mortality in a cohort.Materials/Patients and Methods
Population based cohorts were followed in Montevideo, Santiago and Sao Paulo during 5, 6 and 9 years, respectively. Outcomes included all-cause, cardiovascular, respiratory and cancer mortality; exposures were COPD, forced expiratory volume in one second (FEV1) and forced vital capacity (FVC). Cox regression was used for analyses. Sensitivity, specificity, positive and negative predictive values, receiver operator characteristics curves and Youden''s index were calculated.Results
Main causes of death were cardiovascular, respiratory and cancer. Baseline COPD was associated with overall mortality (HR = 1.43 for FEV1/FVC<LLN; 2.01 for GOLD 2-4; 1.46 for GOLD 1-4; 1.50 for FEV1/FEV6 <LLN). For cardiovascular mortality, significant associations were found with GOLD 2-4 (HR = 2.68) and with GOLD 1-4 (HR = 1.78) for both genders together (not among women). Low FEV1 was risk for overall and respiratory mortality (both genders combined). FVC was not associated with overall mortality. For most COPD criteria sensitivity was low and specificity high. The area under the curve for FEV1 was greater than for FVC for overall and cardiovascular mortality.Answer to the Question
COPD and low FEV1 are important predictors for overall and cardiovascular mortality in Latin America. 相似文献959.
Steven A. Safren Katie B. Biello Laura Smeaton Matthew J. Mimiaga Ann Walawander Javier R. Lama Aadia Rana Mulinda Nyirenda Virginia M. Kayoyo Wadzanai Samaneka Anjali Joglekar David Celentano Ana Martinez Jocelyn E. Remmert Aspara Nair Umesh G. Lalloo Nagalingeswaran Kumarasamy James Hakim Thomas B. Campbell for the PEARLS Study Team 《PloS one》2014,9(8)
960.